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. Several studies have been conducted on the binding affinity of the protein HMGB1a for cisplatin-DNA adducts in numerous sequence contexts, and these studies have produced some apparently inconsistent results. The total DNA concentration, total protein concentration, and fraction of bound DNA can be used to calculate a dissociation constant (K D ) using the method described in the supplementary information of Ref.
(1). The K D values we have calculated from the gel-mobility shift assay data must be regarded as estimates because the values of fraction of bound DNA (θ) have been estimated visually from the sources noted in the table, and because the total protein concentration in Ref. (2) is not obvious it has been assumed 30 nM, the highest value apparently used in that work and consistent with Ref. (3) . The only apparent difference in protocol between these references is the length of time that HMGB1a is incubated with the drug-DNA prior to performing the gel-mobility shift assay: Refs. (2) and (3) incubate for 30 minutes whereas Refs. (4) and (5) incubate for 1 hour. We conjecture that differences in the kinetics of binding lead to differences in the apparent binding affinity, and indeed the binding affinity of the experiments using longer incubation time report similar or greater apparent binding affinity, which is consistent with a kinetic barrier affecting the results obtained with the shorter incubation time. Our equilibration procedure is as follows. First, in constant volume and temperature conditions (NVT), the water and ions were minimized with the conjugate gradient algorithm for 10000 steps, with the DNA subjected to a 500 kcal/mol-A 2 harmonic restraining potential. Second, in NVT conditions, with the DNA restraining potential reduced to 100 kcal/mol-A 2 , the system was heated from 0 to 300 K over 20 ps. Third, in constant pressure and temperature conditions (NPT) and with the restraint reduced to 50 kcal/mol-A 2 the system was relaxed for another 20 ps. Fourth, in NVT, the restraining potential was reduced in three steps (50, 10, and 5 kcal/mol-A 2 ) and minimized for 2000 steps each. Fifth, in NVT with the same 5 kcal/mol-A 2 restraint the system was heated from 10 to 300 K over 20 ps. Sixth, in NPT, the restraint was reduced from 5 to 1 to 0.1 to 0 kcal/mol-A 2 over 20 ps. Seventh, in NVT with no restraints, the system was heated from 10 to 300 K over 20 ps. Finally, the system was heated from 100 to 300 K over 20 ps in NPT. This equilibration procedure was used prior to performing several short simulations to generate initial structures for umbrella sampling (described in Section 3 of the Supporting Material).
Sequence
For systems in the absence of protein, referred to as unbound systems, we used available NMR solution structures of Cp-DNA and Ox-DNA (PDB ID: 2NPW; PDB ID: 1PGC) to develop starting structures for both drugs in four sequence contexts by manually replacing the base pairs flanking the platinated guanines with base pairs from B-DNA using VMD 1.9 (6). The four sequences studied here are: 5′-
, where the sequence context is indicated by bolded text and the platinated guanines are italicized. As in the experimental structures, the drugs were covalently bound to the N7 atoms of the central adjacent guanines (G6 and G7). Undamaged, canonical B-DNA was generated using Nucleic Acid Builder (nab) in AmberTools 1.5 (7) . In all cases where a molecule was manually edited (e.g. mutation of a base pair), the edited structure was subjected to 500 steps of conjugate gradient minimization to eliminate any extremely unfavorable geometry before being used for simulation. Counterions (Na + ) were added to neutralize the system charge. Systems were solvated with TIP3P water molecules with a minimum distance of 10 Å from the solute to the edge of the box; in each case, approximately 5000 to 5500 water molecules were added. Production MD was performed in the NPT ensemble, using Langevin dynamics to maintain a temperature of 300 K and a pressure of 1 atm. The SHAKE algorithm was used to restrain the lengths of all bonds to hydrogen, and a time step of 2 fs was used. We used NAMD 2.9 for all simulations and the Amber ff99 force field (with the recent SB and bsc0 modifications) to parameterize nucleic acids, protein, TIP3P water molecules, and counterions (8) (9) (10) (11) . Force fields for cisplatin, oxaliplatin, and the damaged guanine bases are available in literature (12) (13) (14) (15) ; these are identical to those in our previous work (16) .
(3) Umbrella sampling procedure and details of the finite-temperature string method implementation To obtain bent initial structures, we conducted a single 2 ns simulation for each system (B-, Cp-, and Ox-DNA) in each sequence in which the DNA was gradually bent from 0° to 135°; individual frames were extracted from this trajectory for use in each of 28 sampling windows in 5° increments from 0° to 135°. These were used as starting structures for 1D bending umbrella sampling simulations. These bent starting structures were also used to generate starting structures for 2D deformability umbrella sampling simulations: we performed another set of 2 ns simulations to change the minor groove width in 1 Å intervals over the nearly full range of 11 to 24 Å. Not all minor groove widths were simulated for all bend angles: several of the 24 Å windows were excluded because we found that sampling in these regions was already sufficient. The final structures of these groove-widening simulations were used as the starting structures for 2D deformability umbrella sampling simulations. Each umbrella sampling window was sampled for 10 ns, which we determined was sufficient by gradually increasing the amount per window until the free energy profiles had converged. Each 1D bending free energy profile requires 280 ns of simulation time and each 2D free energy surfaces requires approximately 3740 ns of simulation time.
We implemented the finite-temperature string (FTS) method as detailed in (17) . We used a temperature of 0.5, 20 points on the string, performed 50000 iterations with a time step of 0.01, and used a smoothing coefficient of 0.1. These particular parameters were determined to produce qualitatively reasonable minimum free energy pathways (MFEPs). In particular, the temperature of 0.5 was chosen by visual inspection of the 3D free energy surface to determine the approximate height of the small-scale roughness of the surface, followed by some experimentation to determine a reasonable value for the temperature. At lower temperatures, the pathways are not qualitatively smooth enough, while at higher temperatures numerical instabilities sometimes occur when the random force overwhelms the underlying potential surface, leading to unpredictable behavior. The initial guess for the string was a straight line between the structural coordinates of the unbound and bound states determined from our previous unbiased simulations, and the initial and final points of the string were fixed at these values. Although the FTS method is not typically used with the endpoints fixed, it was necessary in this case because the initial and final points are not free energy minima separated by a free energy barrier. We note that the MFEP calculated without the endpoints fixed lies along the same pathway as with the endpoints fixed but expands to fill a longer portion of the landscape in the same diagonal direction as the MFEP with the endpoints fixed. The free energy gradient in the x-(helical bend) and y-(minor groove width) directions was estimated numerically using a central difference approximation at each point, except for points at the edges of the free energy surface, where either a forward or backward difference was used as appropriate. The code was implemented in MATLAB and modified from the code available at http://www.math.princeton.edu/string/code/ftsMueller.m. 
1D bending free energy profiles of A-tract DNA with varying intrinsic stiffness and curvature Figure S1 . A-tract DNA, defined as 4-6 consecutive A-T base pairs, can show sequence-dependent curvature and stiffness. These adenine-rich sequences are often involved in DNA recognition, such as by the TATA-box binding protein, due to their intrinsic mechanical and structural properties (18, 19) . For this reason, we validated our helical bend reaction coordinate by performing umbrella sampling simulations on several A-tract sequences with known properties: A 4 T 4 (5'-GCAAAATTTTGC-3'), which is intrinsically bent toward the minor groove, the opposite direction that DNA bending occurs with our constraint; T 4 A 4 (5'-GCTTTTAAAAGC-3'), which is intrinsically straight; and (TA) 4 (5'-GCTATATATAGC-3'), which is intrinsically bent toward the major groove (20) (21) (22) . By showing that A 4 T 4 is least deformable, that T 4 A 4 has intermediate deformability, and that (TA) 4 is the most deformable, our method qualitatively captures this known trend. A sequence is considered more deformable if it takes less free energy to reach higher bend angles.
Free energy (kcal/mol)
Bend angle (°) (6) Reproducibility of 1D bending free energy profiles Figure S2 . 1D bending free energy profiles for B-DNA, Cp-DNA, and Ox-DNA in four sequence contexts. The lines denoted by "#1" and "#2" are from two independent sets of umbrella sampling simulations with 10 ns of sampling per window, and the lines denoted by "#1+2" is the free energy profile resulting from using the combined data from #1 and #2 in a WHAM calculation. The two independent trials have converged to yield nearly the same free energy profile.
(a) (b) (c) Free energy (kcal/mol) (9) Reproducibility of 2D deformability free energy landscapes: Ox-TGGA Figure S5 . The deformation free energy landscapes shown in (a-c) are the result of three independent sets of umbrella sampling simulations conducted on Ox-TGGA, i.e. each helical bend and minor groove width window was simulated three times. Qualitatively, it is clear that these independent calculations have produced very similar free energy landscapes. The middle row of plots (e-f) shows the mean of these three independent calculations (e), and the mean ± the standard deviation of the three trials (d, f). In each case, the MFEP calculated on that surface is shown, demonstrating the similarity of the pathways. Finally, (g) and (h) show the free energy profiles along the MFEPs on the surfaces shown in (a-c, e) and (d-f), respectively, and Cp-TGGA is included for comparison. The low variation between the three independent free energy landscapes, and between the MFEPs calculated on the landscapes, is a good indication that each individual umbrella sampling calculation has a sufficient amount of sampling, even for other drug/sequence combinations. Contour lines are separated by 1 kcal/mol. Free energy scale is in kcal/mol. (h) Free energy profiles (g) Free energy profiles (10) Direct linear pathways on 2D free energy landscapes are similar to minimum free energy pathways Figure S6 . Comparison of the free energy profiles along the MFEPs calculated using the finitetemperature string (FTS) method and the free energy profile along a straight line between the initial and final structures. When compared to Fig. 5 in the main text, this demonstrates that the free energy profile along the pathway depends more strongly on the structure of the final (i.e. protein-bound) state than on the specific pathway along the free energy surface. This is sensible because the free energy surfaces are relatively smooth (although not perfectly so).
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